{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:01:28Z","timestamp":1791864088344,"version":"4.3.4"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.bcp.2013.12.013","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T08:53:57Z","timestamp":1388739237000},"page":"12-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Ischemia\/reperfusion injury: Effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition"],"prefix":"10.1016","volume":"88","author":[{"given":"Claudia","family":"Duehrkop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rieben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2013.12.013_bib0005","first-page":"68","article-title":"Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog","volume":"70","author":"Jennings","year":"1960","journal-title":"Arch Pathol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00234-006-0183-z","article-title":"Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies","volume":"49","author":"Pan","year":"2007","journal-title":"Neuroradiology"},{"key":"10.1016\/j.bcp.2013.12.013_bib0015","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1161\/01.STR.28.11.2109","article-title":"Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke","volume":"28","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.bcp.2013.12.013_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.STR.7.2.135","article-title":"A pilot study of urokinase therapy in cerebral infarction","volume":"7","author":"Fletcher","year":"1976","journal-title":"Stroke"},{"key":"10.1016\/j.bcp.2013.12.013_bib0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI200422353","article-title":"Acute renal failure: definitions, diagnosis, pathogenesis, and therapy","volume":"114","author":"Schrier","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2013.12.013_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1741-7015-9-11","article-title":"Advances in understanding ischemic acute kidney injury","volume":"9","author":"Munshi","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/j.bcp.2013.12.013_bib0035","first-page":"65","article-title":"Improved diagnosis of hepatic perfusion disorders: value of hepatic arterial phase imaging during helical CT","volume":"vol. 21","author":"Quiroga","year":"2001"},{"key":"10.1016\/j.bcp.2013.12.013_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2013.02.006","article-title":"Rapidly progressing fatal reperfusion syndrome caused by acute critical ischemia of the lower limb","author":"Szijarto","year":"2013","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bcp.2013.12.013_bib0050","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1084\/jem.183.5.2343","article-title":"Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement","volume":"183","author":"Weiser","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2013.12.013_bib0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1084\/jem.20050390","article-title":"Identification of the target self-antigens in reperfusion injury","volume":"203","author":"Zhang","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2013.12.013_bib0060","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.4049\/jimmunol.159.4.1953","article-title":"Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma","volume":"159","author":"Wuillemin","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0065","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1161\/CIRCULATIONAHA.106.684852","article-title":"Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia","volume":"116","author":"Rehm","year":"2007","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.bcp.2013.12.013_bib0070","doi-asserted-by":"crossref","first-page":"e72059","DOI":"10.1371\/journal.pone.0072059","article-title":"C1 esterase inhibitor reduces lower extremity ischemia\/reperfusion injury and associated lung damage","volume":"8","author":"Duehrkop","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2013.12.013_bib0075","first-page":"3","article-title":"Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo","author":"Orsenigo","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.bcp.2013.12.013_bib0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.coi.2005.06.002","article-title":"Alarmins: chemotactic activators of immune responses","volume":"17","author":"Oppenheim","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0085","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.embor.7400205","article-title":"HMGB1 is an endogenous immune adjuvant released by necrotic cells","volume":"5","author":"Rovere-Querini","year":"2004","journal-title":"Embo Rep"},{"key":"10.1016\/j.bcp.2013.12.013_bib0090","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3892\/etm.2013.1026","article-title":"Dynamic changes in HMGB1 levels correlate with inflammatory responses during cardiopulmonary bypass","volume":"5","author":"Zhang","year":"2013","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.bcp.2013.12.013_bib0095","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1681\/ASN.2009101048","article-title":"HMGB1 contributes to kidney ischemia reperfusion injury","volume":"21","author":"Wu","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2013.05.041","article-title":"The HMGB1-TLR4 axis contributes to myocardial ischemia\/reperfusion injury via regulation of cardiomyocyte apoptosis","author":"Ding","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2013.12.013_bib0105","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/labinvest.2013.66","article-title":"TLR4 as receptor for HMGB1-mediated acute lung injury after liver ischemia\/reperfusion injury","volume":"93","author":"Yang","year":"2013","journal-title":"Lab Invest"},{"key":"10.1016\/j.bcp.2013.12.013_bib0110","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.24501","article-title":"Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice","volume":"54","author":"Huang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2013.12.013_bib0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.surg.2004.05.016","article-title":"Murine hindlimb reperfusion injury can be initiated by a self-reactive monoclonal IgM","volume":"136","author":"Austen","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.bcp.2013.12.013_bib0120","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1016\/j.molimm.2008.06.013","article-title":"Human natural IgM can induce ischemia\/reperfusion injury in a murine intestinal model","volume":"45","author":"Zhang","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0125","doi-asserted-by":"crossref","first-page":"R1675","DOI":"10.1152\/ajpregu.00380.2009","article-title":"Inhibition of rat gut reperfusion injury with an agent developed for the mouse. Evidence that amplification of injury by innate immunity is conserved between two animal species","volume":"298","author":"Afnan","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0130","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/cvr\/cvq141","article-title":"Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction","volume":"87","author":"Haas","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.bcp.2013.12.013_bib0135","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.4049\/jimmunol.0803980","article-title":"Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury","volume":"182","author":"Kulik","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-immunol-030409-101250","article-title":"Properdin: emerging roles of a pattern-recognition molecule","volume":"28","author":"Kemper","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0145","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1016\/j.molimm.2008.06.034","article-title":"Properdin new roles in pattern recognition and target clearance","volume":"45","author":"Kemper","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0150","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1084\/jem.133.4.885","article-title":"The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats","volume":"133","author":"Hill","year":"1971","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2013.12.013_bib0155","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/01.RES.0000232544.90675.42","article-title":"Complement component C3 mediates inflammatory injury following focal cerebral ischemia","volume":"99","author":"Mocco","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.bcp.2013.12.013_bib0160","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.4049\/jimmunol.1201904","article-title":"The alternative complement pathway propagates inflammation and injury in murine ischemic stroke","volume":"189","author":"Elvington","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0165","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.4049\/jimmunol.174.10.6373","article-title":"Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q","volume":"174","author":"Hart","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0170","first-page":"5","article-title":"Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke","author":"Cervera","year":"2010","journal-title":"PLos One"},{"key":"10.1016\/j.bcp.2013.12.013_bib0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1084\/jem.20090633","article-title":"Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D","volume":"207","author":"Takahashi","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2013.12.013_bib0180","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.ajpath.2011.08.040","article-title":"The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury","volume":"179","author":"Zhang","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-7-15","article-title":"Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice","volume":"7","author":"Harhausen","year":"2010","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.bcp.2013.12.013_bib0190","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.4049\/jimmunol.172.6.3869","article-title":"Critical protection from renal ischemia reperfusion injury by CD55 and CD59","volume":"172","author":"Yamada","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0195","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.4049\/jimmunol.1202275","article-title":"Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice","volume":"190","author":"Miwa","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0200","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.2011111072","article-title":"C3a and C5a promote renal ischemia-reperfusion injury","volume":"23","author":"Peng","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0205","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.cardiores.2007.07.016","article-title":"Attenuation of myocardial reperfusion injury in pigs by Mirococept, a membrane-targeted complement inhibitor derived from human CR1","volume":"76","author":"Banz","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.bcp.2013.12.013_bib0210","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejcts.2006.03.012","article-title":"APT070 inhibits complement activation during in vitro cardiopulmonary bypass","volume":"30","author":"De Silva","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.bcp.2013.12.013_bib0215","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.bjp.0706286","article-title":"APT070 (Mirococept), a membrane-localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury","volume":"145","author":"Souza","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0220","doi-asserted-by":"crossref","DOI":"10.1179\/1743132813Y.0000000238","article-title":"Neuroprotective effects of the SCR functional domain of CR1 on acute cerebralischemia and reperfusion injury in rats","author":"Yang","year":"2013","journal-title":"Neurol Res"},{"key":"10.1016\/j.bcp.2013.12.013_bib0225","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1179\/1743132811Y.0000000016","article-title":"The protective effect of SCR(15-18) on cerebral ischemia-reperfusion injury","volume":"33","author":"Li","year":"2011","journal-title":"Neurol Res"},{"key":"10.1016\/j.bcp.2013.12.013_bib0230","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1172\/JCI108978","article-title":"Reduction by cobra venom factor of myocardial necrosis after coronary-artery occlusion","volume":"61","author":"Maroko","year":"1978","journal-title":"J Clin Investig"},{"key":"10.1016\/j.bcp.2013.12.013_bib0235","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.molimm.2009.08.017","article-title":"Humanized cobra venom factor decreases myocardial ischemia-reperfusion injury","volume":"47","author":"Gorsuch","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0240","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neulet.2005.01.027","article-title":"The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats","volume":"380","author":"Figueroa","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bcp.2013.12.013_bib0245","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.112.123968","article-title":"Endogenous and natural complement inhibitor attenuates myocardial injury and arterial thrombogenesis","volume":"126","author":"Pavlov","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2013.12.013_bib0250","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ahj.2006.03.027","article-title":"Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: a systematic overview","volume":"152","author":"Mahaffey","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.bcp.2013.12.013_bib0255","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.athoracsur.2006.02.024","article-title":"Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time","volume":"82","author":"Smith","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bcp.2013.12.013_bib0260","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.297.1.43","article-title":"Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial","volume":"297","author":"Investigators","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2013.12.013_bib0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2012.04.007","volume":"164","author":"Martel","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.bcp.2013.12.013_bib0270","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.CIR.0000087447.12918.85","article-title":"Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial","volume":"108","author":"Granger","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2013.12.013_bib0275","series-title":"HSR Proceedings in intensive care & cardiovascular anesthesia, vol. 3","first-page":"23","article-title":"Pexelizumab and survival in cardiac surgery","author":"Testa","year":"2011"},{"key":"10.1016\/j.bcp.2013.12.013_bib0280","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.trre.2013.04.002","article-title":"Eculizumab in renal transplantation","volume":"27","author":"Legendre","year":"2013","journal-title":"Transplant Rev"},{"key":"10.1016\/j.bcp.2013.12.013_bib0285","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jtcvs.2004.06.048","article-title":"A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings","volume":"129","author":"Keshavjee","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bcp.2013.12.013_bib0290","doi-asserted-by":"crossref","first-page":"II274","DOI":"10.1161\/01.CIR.0000138315.99788.eb","article-title":"Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass","volume":"110","author":"Lazar","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2013.12.013_bib0295","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.20050664","article-title":"Defective thrombus formation in mice lacking coagulation factor XII","volume":"202","author":"Renne","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2013.12.013_bib0300","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1172\/JCI109931","article-title":"Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure","volume":"66","author":"Francis","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2013.12.013_bib0305","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00418.2012","article-title":"The role of fibrinogen in acute ischemic kidney injury","author":"Soerensen-Zender","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0310","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1161\/ATVBAHA.110.213280","article-title":"Protease-activated receptor 2 deficiency reduces cardiac ischemia\/reperfusion injury","volume":"30","author":"Antoniak","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0315","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1084\/jem.20052458","article-title":"Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis","volume":"203","author":"Kleinschnitz","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2013.12.013_bib0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.05.035","article-title":"Case report: a 70-year-old man with undiagnosed factor VII deficiency presented with acute ischemic stroke","author":"Ip","year":"2013","journal-title":"J Stroke Cerebrovasc Dis Off J National Stroke Assoc"},{"key":"10.1016\/j.bcp.2013.12.013_bib0325","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood-2006-03-008870","article-title":"Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury","volume":"109","author":"Sevastos","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2013.12.013_bib0330","doi-asserted-by":"crossref","first-page":"S649","DOI":"10.1016\/S0003-4975(02)04691-X","article-title":"Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury","volume":"75","author":"Chong","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bcp.2013.12.013_bib0335","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0002-9440(10)64824-9","article-title":"Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation","volume":"157","author":"Erlich","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0340","doi-asserted-by":"crossref","first-page":"e1527","DOI":"10.1371\/journal.pone.0001527","article-title":"Anti-human tissue factor antibody ameliorated intestinal ischemia reperfusion-induced acute lung injury in human tissue factor knock-in mice","volume":"3","author":"He","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2013.12.013_bib0345","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.STR.24.6.847","article-title":"Tissue factor contributes to microvascular defects after focal cerebral ischemia","volume":"24","author":"Thomas","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.bcp.2013.12.013_bib0350","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12975-012-0186-5","article-title":"Inhibition of factor XII-mediated activation of factor XI provides protection against experimental acute ischemic stroke in mice","volume":"3","author":"Leung","year":"2012","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.bcp.2013.12.013_bib0355","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jcmg.2012.01.025","article-title":"Selective factor XIIa inhibition attenuates silent brain ischemia: application of molecular imaging targeting coagulation pathway","volume":"5","author":"Chen","year":"2012","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.bcp.2013.12.013_bib0360","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/CIRCULATIONAHA.109.924761","article-title":"Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding","volume":"121","author":"Hagedorn","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2013.12.013_bib0365","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1538-7836.2008.03232.x","article-title":"Active site inhibited factor VIIa attenuates myocardial ischemia\/reperfusion injury in mice","volume":"7","author":"Loubele","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.bcp.2013.12.013_bib0370","doi-asserted-by":"crossref","first-page":"H1507","DOI":"10.1152\/ajpheart.2000.278.5.H1507","article-title":"Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits","volume":"278","author":"Golino","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0375","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.STR.32.1.22","article-title":"Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the TOPAS trial. Therapy of Patients With Acute Stroke (TOPAS) Investigators","volume":"32","author":"Diener","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.bcp.2013.12.013_bib0380","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(13)70079-6","article-title":"Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials","volume":"12","author":"Whiteley","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0385","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2013.12.013_bib0390","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12028-011-9591-y","article-title":"Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment","volume":"16","author":"Watanabe","year":"2012","journal-title":"Neurocritic Care"},{"key":"10.1016\/j.bcp.2013.12.013_bib0395","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-9560-11-14","article-title":"Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost\/utility analysis using an analytic decision model","volume":"11","author":"Nshimyumukiza","year":"2013","journal-title":"Thrombosis J"},{"key":"10.1016\/j.bcp.2013.12.013_bib0400","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00007890-197804000-00001","article-title":"Trasylol (aprotinin) and kidney preservation","volume":"25","author":"Godfrey","year":"1978","journal-title":"Transplantation"},{"key":"10.1016\/j.bcp.2013.12.013_bib0405","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa051379","article-title":"Multicenter Study of Perioperative Ischemia Research G, Ischemia R, Education F. The risk associated with aprotinin in cardiac surgery","volume":"354","author":"Mangano","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2013.12.013_bib0410","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/bja\/aet008","article-title":"Aprotinin and cardiac surgery: a sorry tale of evidence misused","volume":"110","author":"McMullan","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bcp.2013.12.013_bib0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.03.026","article-title":"Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II","author":"Joseph","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0420","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1182\/blood-2011-05-355248","article-title":"Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding","volume":"118","author":"Revenko","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2013.12.013_bib0425","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejheart.2008.02.002","article-title":"Tissue kallikrein deficiency aggravates cardiac remodelling and decreases survival after myocardial infarction in mice","volume":"10","author":"Pons","year":"2008","journal-title":"Eur J Heart Failure"},{"key":"10.1016\/j.bcp.2013.12.013_bib0430","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1073\/pnas.0701617104","article-title":"Bradykinin B1 and B2 receptors both have protective roles in renal ischemia\/reperfusion injury","volume":"104","author":"Kakoki","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2013.12.013_bib0435","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/01.HYP.0000214867.35632.0e","article-title":"Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor","volume":"47","author":"Xia","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2013.12.013_bib0440","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/STROKEAHA.108.526673","article-title":"Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema","volume":"40","author":"Austinat","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.bcp.2013.12.013_bib0445","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1567-5769(02)00022-X","article-title":"Detrimental implication of B1 receptors in myocardial ischemia: evidence from pharmacological blockade and gene knockout mice","volume":"2","author":"Lagneux","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0450","first-page":"3","article-title":"Brabykinin B1 receptor antagonism is beneficial in renal ischemia-reperfusion injury","author":"Wang","year":"2008","journal-title":"PLos One"},{"key":"10.1016\/j.bcp.2013.12.013_bib0455","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1089\/hum.2006.17.1201","article-title":"Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation","volume":"17","author":"Chao","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.bcp.2013.12.013_bib0460","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/jpet.106.105064","article-title":"Selective inhibition of plasma kallikrein protects brain from reperfusion injury","volume":"318","author":"Storini","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2013.12.013_bib0465","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1136\/heartjnl-2011-300323","article-title":"Bradykinin does not mediate remote ischaemic preconditioning or ischaemia-reperfusion injury in vivo in man","volume":"97","author":"Pedersen","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.bcp.2013.12.013_bib0470","first-page":"124","article-title":"The kinin system\u2013bradykinin: biological effects and clinical implications. Multiple role of the kinin system\u2013bradykinin","volume":"11","author":"Golias","year":"2007","journal-title":"Hippokratia"},{"key":"10.1016\/j.bcp.2013.12.013_bib0475","doi-asserted-by":"crossref","first-page":"e20036","DOI":"10.1371\/journal.pone.0020036","article-title":"Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1","volume":"6","author":"Dobo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2013.12.013_bib0480","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.molimm.2011.08.021","article-title":"Mechanisms of mannose-binding lectin-associated serine proteases-1\/3 activation of the alternative pathway of complement","volume":"49","author":"Banda","year":"2011","journal-title":"Mol Immunol"},{"key":"10.1016\/j.bcp.2013.12.013_bib0485","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejcts.2007.04.038","article-title":"Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study","volume":"32","author":"Fattouch","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.bcp.2013.12.013_bib0490","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/jth.12243","article-title":"Antithrombin is protective against myocardial ischemia and reperfusion injury","volume":"11","author":"Wang","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.bcp.2013.12.013_bib0495","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1093\/eurheartj\/ehi421","article-title":"Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia\/reperfusion injury","volume":"26","author":"Banz","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.bcp.2013.12.013_bib0500","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1600-6143.2003.00306.x","article-title":"Endothelial cell protection by dextran sulfate: a novel strategy to prevent acute vascular rejection in xenotransplantation","volume":"4","author":"Laumonier","year":"2004","journal-title":"Am J Transplant"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295213007971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295213007971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T12:16:11Z","timestamp":1688904971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295213007971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0006295213007971"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2013.12.013","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ischemia\/reperfusion injury: Effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2013.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}